Prophylaxis against nerve agent intoxications

Defence Science Journal

Volumn 56, Issue 5, 2006, Pages 775-784

  Patocka, Jiri ^a,b   Jun, Daniel ^a   Bajgar, Jiri ^a   Kuca, Kamil ^a  

^a University of South Bohemia ^*

^b UNIVERSITY OF SOUTH BOHEMIA   (Czech Republic)

Author keywords

Acetylcholinesterase; Bioscavengers; Cholinesterases; Gene therapy; Inhibitors; Nerve agents; Organophosphates; Poisoning; Pretreatment; Prophylaxis

Indexed keywords

GENES; GENETIC ENGINEERING; HYDROLYSIS; NEUROLOGY; TOXIC MATERIALS;

ACETYLCHOLINESTERASE; BIOSCAVENGERS; CHOLINESTERASES; GENE THERAPY; INHIBITORS; NERVE AGENTS; ORGANOPHOSPHATES; POISONING; PRETREATMENT; PROPHYLAXIS;

ENZYMES;

EID: 33847396968     PISSN: 0011748X     EISSN: None     Source Type: Journal    
DOI: 10.14429/dsj.56.1941     Document Type: Review

References (69)

1. Martin, T. & Lobert, S. Chemical warfaretoxicity of nerve agents. Crit. Care Nurse, 2003, 23, 21-22.
2. Chemical Weapons Convention: Convention on the Prohibition of the Development, Production, Stockpiling and Use of Chemical Weapons and on their Destruction. OPCW, Paris, 1993.
3. Bajgar, J. Present views on toxidynamics of soman poisoning. Acta Medica (Hradec Kralove), 1996, 39, 101-05.
4. Bajgar, J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv. Clin. Chem., 2004, 38, 151-216.
5. Das Gupta, S.; Ghosh, A.K.; Chowdhri B.L.; Asthana, S.N. & Batra, B.S. Actions and interactions of cholinolytics and cholinesterase reactivators in the treatment of acute organophosphorus toxicity. Drug. Chem. Toxicol., 1991, 14, 283-91.
6. Heilbronn, E. & Tolagen, B. Toxogonin in sarin soman and tabun poisoning. Biochemistry Pharmacology, 1965, 14, 73-77.
7. Luo, C. & Liang, J. Evaluation of combined toxic effects of GB/GF and efficacy of jielin injection against combined poisoning in mice. Toxicology Letters, 1997, 92, 195-200.
8. Bajgar, J. Prophylaxis against organophosphorus poisoning. J. Med. Chem. Def., 2004, 1, 1-16.
9. Wolthuis, O.L.; Berends, F. & Meeter, E. Problems in the therapy of soman poisoning. Fundam. Appl. Toxicol., 1981, 1, 183-92.
10. Dunn, M.A. & Sidell, F.R. Progress in medical defence against nerve agents. JAMA, 1989, 262, 649-52.
11. Berry, W.K. & Davies, D.R. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methyl phosphonofluoridate. Biochemistry Pharmacology, 1970, 19, 927-34.
12. Somani, S.M. & Dube, S.N. Physostigmine - an overview as pretreatment drug for organophosphate intoxication. Int. J. Clin. Pharmacol. Ther. Toxicol., 1989, 27, 367-87.
13. Bajgar, J.; Fusek, J. & Vachek, J. Treatment and prophylaxis against nerve agent poisoning. ASA Newsletter, 1994, 43, 10-11.
14. Ashani, Y.; Leader, H.; Raveh, L.; Bruckstein, R. & Spiegelstein, M. In vitro and in vivo protection of acetylcholinesterase against organophosphate poisoning by pretreatment with a novel derivative of 1,3,2-dioxaphosphorinane 2-oxide. J. Med. Chem. 1983, 26, 145-52.
15. Harris, L. & Stitcher, D. Protection against diisopropylfluorophosphate intoxication by pyridostigmine and physostigmine in combination with atropine and mecamylamine. Archive in Pharmacology, 1984, 327, 64-9.
16. Gajewski, D. & Owczarczyk, H. Protective effect of some pyridinium salts on acetylcholinesterase against organophosphate inhibition. Acta Physiol. Pol., 1980, 31, 93-99.
17. Puu, G. Ketamine protects acetylcholinesterase against in vitro inhibition by sarin. Biochemistry Pharmacology, 1988, 37, 969-70.
18. Koutsoviti-Papadopoulou, M.; Kounenis, G. & Elezoglou, V. Ketamine protects acetylcholinesterase against inhibition by propoxur and phoxim. Pharmacology Research, 1994, 30, 117-22.
19. Dawson, R.M. Tacrine slows the rate of ageing of sarin-inhibited acetylcholinesterase, Neuroscience Letters, 1989, 22, 227-30.
20. Fricke, R.F.; Koplovitz, I.; Scharf, B.A.; Rockwood, G.A.; Olson, C.T.; Hobson, D.W. & Blank, J.A. Efficacy of tacrine as a nerve agent pretreatment. Drug Chem. Toxicol., 1994, 17, 15-34.
21. Patocka, J. & Kassa, J. Huperzine - A prospective prophylactic antidote against organophosphate warfare agent poisoning. ASA Newsletter, 1999, 99, 16-19.
22. Lallement, G.; Baille, V.; Baubichon, D.; Carpentier, P.; Collombet, J.M.; Filliat, P.; Foquin, A.; Four, E.; Masqueliez, C.; Testylier, G.; Tonduli, L. & Dorandeu, F. Review of the value of huperzine as pretreatment of organophosphate poisoning. Neurotoxicology, 2002, 23, 1-5.
23. Gordon, J.J.; Leadbeater, L. & Maidment, M.P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol., 1978, 43, 207-16.
24. Deshpande, S.S.; Viana, G.B.; Kauffman, F.C.; Rickett, D.L. & Albuquerque, E.X. Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning. Fundam. Appl. Toxicol., 1986, 6, 566-77.
25. Patocka, J. Effect of pyridostigmine and syntostigmine pretreatment on the inhibition of acetylcholinesterases by O-pinacolyl- methylphosphonofluoridate. In vitro experiments with rat tissues. Biomed. Biochim. Acta, 1989, 48, 715-20.
26. Solana, R.P.; Gennings, C.; Carter, W.H. (Jr); Anderson, D.; Lennox, W.J.; Carchman, R.A. & Harris, L.W. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure. Fundam. Appl. Toxicol., 1990, 15, 814-19.
27. Tuovinen, K.; Kaliste-Korhonen, E.; Raushel, F.M. & Hanninen, O. Success of pyridostigmine, physostigmine, eptastigmine and phosphotriesterase treatments in acute sarin intoxication. Toxicology, 1999, 15, 169-78.
28. Tuovinen, K. & Hanninen, O. Protection of mice against soman by pretreatment with eptastigmine and physostigmine. Toxicology, 1999, 139, 233-41.
29. Miller, S.A.; Blick, D.W. & Kerenyi, S.Z. Efficacy of physostigmine as a pretreatment for organophosphate poisoning. Pharmacol. Biochem. Behav., 1993, 44 (2), 343.
30. Marino, M.T.; Schuster, B.G.; Brueckner, R.P.; Lin, E.; Kaminskis, A. & Lasseter, K.C. Population pharmacokinetics and pharmacodynamics of pyridostigmine bromide for prophylaxis against nerve agents in humans. J. Clin. Pharmacol., 1998, 38, 227-35.
31. Dirnhuber, P.; French, M.C.; Green, D.M.; Leadbeater, L. & Stratton, J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol., 1979, 31, 295-99.
32. th Medical Chemical Defence Bioscience Review, Aberdeen Proving Ground, Md: US Army Medical Research Institute of Chemical Defence, 1987. pp. 227-34.
33. Leadbeater, L. When all else fails. Chemistry of Britain, 1988, 24, 684-87.
34. Koplovitz, I.; Harris, L.W.; Anderson, D.R.; Lennox, W.J. & Stewart, J.R. Reduction by pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents. Fundam. Appl. Toxicol., 1992, 18, 102-06.
35. Jeevaratnam, K.; Das Gupta, S.; Pravinkumar; Pant, S.C.; Sachan, A.S.; Selvamurthy, W.; Ray U.S.; Mukhopadhyay, S. & Purkayastha, S.S. Physiological, biochemical and histological changes due to physostigmine in monkeys. Indian J. Physiol. Pharmacol., 1998, 42, 25-38.
36. Das Gupta, S.; Ghosh, A.K. & Jeevarathinam, K. Beneficial effect of carbamates against fluostigmine poisoning in rats. Pharmazie, 1987, 42, 206-07.
37. Das Gupta, S.; Bhattacharya, R.; Purnanand & Pant, B.P. Protection studies on anticholinesterase agents in rats. Pharmazie, 1990, 45, 801-02.
38. Philippens, I.H.; Melchers, B.P.; Olivier, B. & Bruijnzeel, P.L. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol. Biochem. Behav., 2000, 65, 175-82.
39. Meshulam, Y.; Cohen, G.; Chapman, S.; Alkalai, D. & Levy, A. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine. J. Appl. Toxicol., 2001, 21 (Suppl 1), S75-S78.
40. Kassa, J. & Vachek, J. A comparison of the efficacy of pyridostigmine alone and the combination of pyridostigmine with anticholinergic drugs as pharmacological pretreatment of tabunpoisoned rats and mice. Toxicology, 2002, 177, 179-85.
41. th International CB Medical Treatment Symposium, 25-30 April 2004, Spiez, Switzerland. Technical Program Abstr. No. 22, p. 20.
42. Kassa, J. & Fusek, J. The positive influence of a cholinergic-anticholinergic pretreatment and antidotal treatment on rats poisoned with supralethal doses of soman. Toxicology, 1998, 128, 1-7.
43. Kassa, J.; Vachek, J.; Bajgar, J. & Fusek, J. A combination of pyridostigmine with anticholinergic drugs: Effective pharmacological pretreatment of soman-poisoned mice. ASA Newsletter, 2001, 84, 16-19.
44. Cook, I.E.; Wenger, C.B. & Kolka, M.A. Chronic pyridostigmine bromide administration: Side effects among soldiers working in a desert environment. Military Medicine, 1992, 157, 250-54.
45. Nicolson, G.L. Mycoplasma infections in Gulf war illnesses: Results of a preliminary study on the prevalence of mycoplasmal infections in desert storm veterans with chronic fatigue syndrome: President's Panel on Gulf war illness, 14-16 August 1995.
46. Kluwe, W.M.; Page, J.G.; Toft, J.D.; Ridder, W.E. & Chung, H. Pharmacological and toxicological evaluation of orally administered pyridostigmine in dogs. Fundam. Appl. Toxicol., 1990, 14, 40-53.
47. Kassa, J. The effect of panpal prophylaxis on acetylcholinesterase activity in the blood, diaphragm and various parts of the brain in rats during treated and untreated poisoning with the organophosphorus insecticide phosdrine. Ceska Slov. Farm., 2000, 49, 37-40.
48. Das Gupta, S. Medical protection against organophosphorus toxicity. In. Enzymes of the Cholinesterase Family, edited by D.M. Quinn; A.S. Balasubramanian; B.P. Doctor & P. Taylor. Plenum Publishing Co. Ltd., NewYork and London, 1995. pp. 228-229.
49. rd Congress Toxicology in Developing Countries, 19-23 November 1995, Cairo, Egypt, Cairo, 1996, 1, 223-36.
50. Gupta, R.C. Prophylaxis and treatment against the toxicity of organophosphate (OP) compounds in rat by memantine and atropine. Toxicologist, 1987, 7, 1103.
51. Gupta, R.C. & Kadel, W.L. Methyl parathion acute toxicity: Prophylaxis and therapy with memantine and atropine. Arch. Int. Pharmacodyn. Ther., 1990, 305, 208-21.
52. Gupta, R.C. & Dettbarn, W.D. Potential of memantine, D-tubocurarine, and atropine in preventing acute toxic myopathy induced by organophosphate nerve agents: Soman, sarin, tabun and VX. Neurotoxicology, 1992, 13, 649-61.
53. McLean, M.J.; Gupta, R.C.; Dettbarn, W.D. & Wamil, A.W. Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat. Toxicol. Appl. Pharmacol., 1992, 112, 95-103.
54. Deshpande, S.S.; Smith, C.D. & Filbert, M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Archive in Toxicology, 1995, 69, 384-90.
55. Galli, A. & Mori, F. Acetylcholinesterase inhibition and protection by dizocilpine (MK-801) enantiomers. J. Pharm. Pharmacol., 1996, 48, 71-6.
56. Doctor, B.P.; Blick, D.W.; Caranto, G.; Castro, C.A.; Gentry, M.K.; Larrison, R.; Maxwell, D.M.; Murphy, M.R.; Schutz, M. & Waibel, K. Cholinesterases as scavengers for organophosphorus compounds: Protection of primate performance against soman toxicity. Chem. Biol. Interact., 1993, 87, 285-93.
57. Maxwell, D.M.; Castro, C.A.; De La Hoz, D.M.; Gentry, M.K.; Gold, M.B.; Solana, R.P.; Wolfe, A.D. & Doctor, B.P. Protection of rhesus monkeys against soman and prevention of performance decrement by pretreatment with acetylcholinesterase. Toxicol. Appl. Pharmacol., 1992, 115, 44-49.
58. Sweeney, R.E. & Maxwell, D.M. A theoretical model of the competition between hydrolase and carboxylesterase in protection against organophosphorus poisoning. Mathematical Biosciences, 1999, 160, 175-90.
59. Wolfe, A.D.; Rush, R.S.; Doctor, B.P.; Koplovitz, I. & Jones, D. Acetylcholinesterase prophylaxis against organophosphate toxicity. Fundam. Appl. Toxicol., 1987, 9, 266-70.
60. Ashani, Y.; Shapira, S.; Levy, D.; Wolfe, A.D.; Doctor, B.P. & Raveh, L. Butyrylcholinesterase and acetylcholinesterase prophylaxis against soman poisoning in mice. Biochemistry Pharmacology, 1991, 41, 37-41.
61. Purshottam, T. & Kaveeshwar, U. Comparative efficacy of exogenous acetylcholinesterase administration on soman and dichlorvos toxicity in rats. Indian. J. Exp. Biol., 1993, 31, 365-68.
62. Sevelova, L.; Bajgar, J.; Saxena, A. & Doctor, B.P. Protective effect of equine butyrylcholinesterase in inhalation intoxication of rats with sarin: Determination of blood and brain cholinesterase activities. Inhal. Toxicology, 2004, 16, 531-36.
63. Maxwell, D.M. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds. Toxicol. Appl. Pharmacol., 1992, 114, 306-12.
64. Grunwald, J.; Marcus, D.; Papier, Y.; Raveh, L.; Pittel, Z. & Ashani, Y. Large-scale purification and long-term stability of human butyrylcholinesterase: A potential bioscavenger drug. J. Biochem. Biophys. Methods., 1997, 34, 123-35.
65. Mor, T.S.; Sternfeld, M.; Soreq, H.; Arntzen, C.J. & Mason, H.S. Expression of recombinant human acetylcholinesterase in transgenic tomato plants. Biotechnology Bioengineering, 2001, 75, 259-66.
66. Broomfield, C.A.; Lockdridge, O.; Millard, C.B. & Lenz, D.E. Design and construction of butyrylcholinesterase mutants that have organophosphorus acid anhydride hydrolase activity (abstract). In m-CB Medical Treatment Symposium, Hradec Králové, 26-30 May 1997. pp. 13-14.
67. Cowan, J.; Sinton, C.M.; Varley, A.W.; Wians, F.H.; Haley, R.W. & Munford, R.S. Gene therapy to prevent organophosphate intoxication. Toxicol. Appl. Pharmacol., 2001, 173, 1-6.
68. Hunter, K.W. (Jr); Lenz, D.E.; Brimfield, A.A. & Naylor J.A. Quantification of the organophosphorus nerve agent soman by competitive inhibition enzyme immunoassay using monoclonal antibody. FEBS Letters, 1982, 149, 147-51.
69. Lenz, D.E.; Brimfield, A.A.; Hunter, K.W. (Jr); Benschop, H.P.; de Jong, L.P.; van Dijk, C. & Clow, T.R. Studies using a monoclonal antibody against soman. Fundam. Appl. Toxicol., 1984, 4, 156-64.